Therefore, it can be summarized that the downregulation of K18 activates the NF-κB/Snail signaling pathway to induce the EMT and enhance the expression of BCRP to enable breast cancer cells to acquire MDR. This evidence concerns the gene NFKB1 and breast carcinoma.